PHILADELPHIA, PA — Dr. Martin Gershon, a renowned figure in healthcare innovation and venture capital, will headline the 2024 Investor Capital Expo hosted by Keiretsu Forum. The event is set for October 31 at Convene City View in Philadelphia, PA.
Dr. Gershon, Managing Partner and Chief Investment Officer of Endeavor Venture Funds and Endeavor Venture Studio, is acclaimed for his transformative impact in life sciences and healthcare startups. With over 100 investments and 24 successful exits under his leadership, Endeavor is at the forefront of innovation, particularly in AI-powered drug discovery.
His keynote, “Pioneering Healthcare Innovation: Investment Strategies in AI Drug Discovery,” will explore the burgeoning opportunities AI presents in drug development, offering insights into strategic investments and future trends set to redefine the sector.
Keiretsu Forum, a leader in early-stage innovation, hosts the Investor Capital Expo as a pivotal event for angel investors, venture capitalists, and entrepreneurs. The gathering highlights high-potential startups that have passed Keiretsu’s rigorous due diligence process, fostering networking and knowledge-sharing among industry leaders.
“Dr. Gershon’s expertise in healthcare and AI makes him an ideal keynote speaker for this year’s Expo,” stated Howard Lubert, Regional President of Keiretsu Forum, acknowledging Dr. Gershon’s role in advancing life-saving technologies and AI innovations.
Event Details:
- Date: October 31, 2024
- Time: 8:00 AM – 6:00 PM EDT
- Location: Convene City View, 30 S 17th St, Philadelphia, PA
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.